A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children.

Background: Nitric oxide (NO) is a mediator of immunity to malaria, and genetic polymorphisms in the promoter of the inducible NO synthase gene (NOS2) could modulate production of NO. We postulated that NOS2 promoter polymorphisms would affect resistance to severe malaria.Methods: We assessed genomi...

Descripción completa

Detalles Bibliográficos
Publicado en:Lancet Vol. 360; no. 9344; pp. 1468 - 1476
Autores principales: Hobbs, Maurine R, Udhayakumar, Venkatachalam, Levesque, Marc C, Booth, Jennifer, Roberts, Jacquelin M, Tkachuk, Ariana N, Pole, Ann, Coon, Hilary, Kariuki, Simon, Nahlen, Bernard L, Mwaikambo, Esther D, Lal, Altaf L, Granger, Donald L, Anstey, Nicholas M, Weinberg, J Brice
Formato: research Journal Article
Publicado: Lancet 11/9/2002
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=7736584&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 7736584
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01406736
        LAN
      jtl: Lancet
      issn: 01406736
      maglogo: N
    pubinfo:
      dt: 11/9/2002
      vid: 360
      iid: 9344
      pid: 1297
      pub: Lancet
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        7736584
        7736584
        NLM12433515
        7736584
        10.1016/S0140-6736(02)11474-7
        NLM12433515
        7736584
      ppf: 1468
      ppct: 8
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children.
      aug:
        au:
          Hobbs, Maurine R
          Udhayakumar, Venkatachalam
          Levesque, Marc C
          Booth, Jennifer
          Roberts, Jacquelin M
          Tkachuk, Ariana N
          Pole, Ann
          Coon, Hilary
          Kariuki, Simon
          Nahlen, Bernard L
          Mwaikambo, Esther D
          Lal, Altaf L
          Granger, Donald L
          Anstey, Nicholas M
          Weinberg, J Brice
      sug:
        subj:
          Oxidoreductases
          Malaria Immunology
          Immunity
          Polymorphism, Genetic
          Nitric Oxide
          Male
          Anemia Immunology
          Malaria Complications
          Infant
          Child
          Malaria Metabolism
          Child, Preschool
          Malaria
          Tanzania
          Anemia Etiology
          Kenya
          Parasitemia Immunology
          Sequence Analysis
          Female
          Clinical Assessment Tools
          Funding Source
          Human
          Infant: 1-23 months
          Child: 6-12 years
          Child, Preschool: 2-5 years
          Male
          Female
      ab: Background: Nitric oxide (NO) is a mediator of immunity to malaria, and genetic polymorphisms in the promoter of the inducible NO synthase gene (NOS2) could modulate production of NO. We postulated that NOS2 promoter polymorphisms would affect resistance to severe malaria.Methods: We assessed genomic DNA from healthy children and from those diagnosed with malaria from Tanzania (n=47 and n=138, respectively) and Kenya (n=1106) for polymorphisms by single-stranded conformational polymorphism (SSCP) analysis and sequencing. We also measured in-vivo NO production in Tanzanian children.Findings: We identified a novel single nucleotide polymorphism, -1173 C-->T, in the NOS2 promoter that was significantly associated with protection from symptomatic malaria (odds ratio 0.12, 95% CI 0.03-0.48, p=0.0006) in 179 Tanzanian children, and significantly associated with protection from severe malarial anaemia (adjusted relative risk 0.25, 95% CI 0.09-0.66, p=0.0005) in 1106 Kenyan children studied over 5 years. The risk of parasitaemia was not significantly different in wild-type or -1173 C-->T individuals. -1173 C-->T protection in Tanzanians was independent of the previously recognised NOS2-954 G-->C polymorphism. The (CCTTT)(n) NOS2 polymorphism (Tanzania and Kenya) was not associated with severe malaria outcomes. -1173 C-->T was associated with increased fasting urine and plasma NO metabolite concentrations in Tanzanian children, suggesting that the polymorphism was functional in vivo. Interpretation The NOS2 promoter -1173 C-->T single nucleotide polymorphism is associated with protection against cerebral malaria and severe malarial anaemia. Increased NO production in individuals with the -1173 C-->T polymorphism lends support to a protective role for NO against these syndromes. Targeted interventions to increase NO delivery or production could provide novel preventive and therapeutic strategies against these major causes of mortality in African children.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N